These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 22155822)
1. Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study. Erdem H; Ulu-Kilic A; Kilic S; Karahocagil M; Shehata G; Eren-Tulek N; Yetkin F; Celen MK; Ceran N; Gul HC; Mert G; Tekin-Koruk S; Dizbay M; Inal AS; Nayman-Alpat S; Bosilkovski M; Inan D; Saltoglu N; Abdel-Baky L; Adeva-Bartolome MT; Ceylan B; Sacar S; Turhan V; Yilmaz E; Elaldi N; Kocak-Tufan Z; Ugurlu K; Dokuzoguz B; Yilmaz H; Gundes S; Guner R; Ozgunes N; Ulcay A; Unal S; Dayan S; Gorenek L; Karakas A; Tasova Y; Usluer G; Bayindir Y; Kurtaran B; Sipahi OR; Leblebicioglu H Antimicrob Agents Chemother; 2012 Mar; 56(3):1523-8. PubMed ID: 22155822 [TBL] [Abstract][Full Text] [Related]
2. Management of neurobrucellosis: an assessment of 11 cases. Gul HC; Erdem H; Gorenek L; Ozdag MF; Kalpakci Y; Avci IY; Besirbellioglu BA; Eyigun CP Intern Med; 2008; 47(11):995-1001. PubMed ID: 18520109 [TBL] [Abstract][Full Text] [Related]
3. Epidemiological, clinical, biochemical, and treatment characteristics of brucellosis cases in Turkey. Arslan M; Ertunç B; Düz ME; Menekşe E; Avci BY; Avci E; Yilmaz G J Infect Dev Ctries; 2024 Jul; 18(7):1066-1073. PubMed ID: 39078792 [TBL] [Abstract][Full Text] [Related]
4. Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis. Ranjbar M; Keramat F; Mamani M; Kia AR; Khalilian FO; Hashemi SH; Nojomi M Int J Infect Dis; 2007 Mar; 11(2):152-6. PubMed ID: 16798042 [TBL] [Abstract][Full Text] [Related]
5. First report of probable neurobrucellosis in Australia. Munckhof WJ; Jennison AV; Bates JR; Gassiep I Med J Aust; 2013 Sep; 199(6):423-5. PubMed ID: 24033218 [TBL] [Abstract][Full Text] [Related]
6. Comparison of five antimicrobial regimens for the treatment of brucellar spondylitis: a prospective, randomized study. Bayindir Y; Sonmez E; Aladag A; Buyukberber N J Chemother; 2003 Oct; 15(5):466-71. PubMed ID: 14598939 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy of two months of treatment with co-trimoxazole plus doxycycline vs. co-trimoxazole plus rifampin in brucellosis. Roushan MR; Gangi SM; Ahmadi SA Swiss Med Wkly; 2004 Sep; 134(37-38):564-8. PubMed ID: 15551160 [TBL] [Abstract][Full Text] [Related]
8. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial. Hashemi SH; Gachkar L; Keramat F; Mamani M; Hajilooi M; Janbakhsh A; Majzoobi MM; Mahjub H Int J Infect Dis; 2012 Apr; 16(4):e247-51. PubMed ID: 22296864 [TBL] [Abstract][Full Text] [Related]
9. Comparison of three different combination therapies in the treatment of human brucellosis. Ersoy Y; Sonmez E; Tevfik MR; But AD Trop Doct; 2005 Oct; 35(4):210-2. PubMed ID: 16354469 [TBL] [Abstract][Full Text] [Related]
10. Tricky brucellosis. Yaghoobi MH; Siroos B; Foroumandi M; Gharabaghi MA BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23709547 [TBL] [Abstract][Full Text] [Related]
12. Unusual presentations of pediatric neurobrucellosis. Budnik I; Fuchs I; Shelef I; Krymko H; Greenberg D Am J Trop Med Hyg; 2012 Feb; 86(2):258-60. PubMed ID: 22302859 [TBL] [Abstract][Full Text] [Related]
13. Dual versus triple therapy for uncomplicated brucellosis: A retrospective cohort study. Al-Madfaa RO; Alalawi MA; Basudan LO; Alhejaili SF; Eljaaly K; Madani TA; Thabit AK J Infect Dev Ctries; 2020 Dec; 14(12):1380-1386. PubMed ID: 33378279 [TBL] [Abstract][Full Text] [Related]
14. Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load. Vrioni G; Bourdakis A; Pappas G; Pitiriga V; Mavrouli M; Pournaras S; Tsakris A Antimicrob Agents Chemother; 2014 Dec; 58(12):7541-4. PubMed ID: 25246401 [TBL] [Abstract][Full Text] [Related]
15. Early clinical response to different therapeutic regimens for human brucellosis. Malik GM Am J Trop Med Hyg; 1998 Feb; 58(2):190-1. PubMed ID: 9502602 [TBL] [Abstract][Full Text] [Related]
16. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas. Solera J; Rodríguez-Zapata M; Geijo P; Largo J; Paulino J; Sáez L; Martínez-Alfaro E; Sánchez L; Sepulveda MA; Ruiz-Ribó MD Antimicrob Agents Chemother; 1995 Sep; 39(9):2061-7. PubMed ID: 8540716 [TBL] [Abstract][Full Text] [Related]
17. [Antibiotic treatment of brucellosis]. Bertrand A Presse Med; 1994 Jun; 23(24):1128-31. PubMed ID: 7971834 [TBL] [Abstract][Full Text] [Related]
18. A rare case of seronegative neurobrucellosis. Tekin-Koruk S; Duygu F; Gursoy B; Karaagac L; Bayraktar M Ann Saudi Med; 2010; 30(5):412-4. PubMed ID: 20697164 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis. Saltoglu N; Tasova Y; Inal AS; Seki T; Aksu HS Saudi Med J; 2002 Aug; 23(8):921-4. PubMed ID: 12235463 [TBL] [Abstract][Full Text] [Related]
20. Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis. Ariza J; Gudiol F; Pallarés R; Rufí G; Fernández-Viladrich P Antimicrob Agents Chemother; 1985 Oct; 28(4):548-51. PubMed ID: 4073878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]